185 related articles for article (PubMed ID: 9517783)
1. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
Ravelli A; Ballardini G; Viola S; Villa I; Ruperto N; Martini A
J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
[TBL] [Abstract][Full Text] [Related]
2. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
Carneiro JR; Sato EI
J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate in nonrenal lupus and undifferentiated connective tissue disease--a review of 36 patients.
Wise CM; Vuyyuru S; Roberts WN
J Rheumatol; 1996 Jun; 23(6):1005-10. PubMed ID: 8782131
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate therapy in childhood systemic lupus erythematosus.
Abud-Mendoza C; Sturbaum AK; Vazquez-Compean R; Gonzalez-Amaro R
J Rheumatol; 1993 Apr; 20(4):731-3. PubMed ID: 8496874
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis.
Rahman P; Humphrey-Murto S; Gladman DD; Urowitz MB
J Rheumatol; 1998 Feb; 25(2):243-6. PubMed ID: 9489814
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate in systemic lupus erythematosus.
Walz LeBlanc BA; Dagenais P; Urowitz MB; Gladman DD
J Rheumatol; 1994 May; 21(5):836-8. PubMed ID: 8064722
[TBL] [Abstract][Full Text] [Related]
7. A 2 year, open ended trial of methotrexate in systemic lupus erythematosus.
Wilson K; Abeles M
J Rheumatol; 1994 Sep; 21(9):1674-7. PubMed ID: 7799348
[TBL] [Abstract][Full Text] [Related]
8. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
Whittle SL; Hughes RA
Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
[TBL] [Abstract][Full Text] [Related]
9. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
Pusongchai T; Jungthirapanich J; Khositseth S
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
Aringer M; Graninger WB; Steiner G; Smolen JS
Arthritis Rheum; 2004 Oct; 50(10):3161-9. PubMed ID: 15476222
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.
Islam MN; Hossain M; Haq SA; Alam MN; Ten Klooster PM; Rasker JJ
Int J Rheum Dis; 2012 Feb; 15(1):62-8. PubMed ID: 22324948
[TBL] [Abstract][Full Text] [Related]
12. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
13. [Methotrexate treatment in refractory juvenile rheumatoid arthritis].
Brik R
Harefuah; 1998 Dec; 135(11):509-11, 567. PubMed ID: 10911466
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
[TBL] [Abstract][Full Text] [Related]
15. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.
Stone JH; Tun W; Hellman DB
J Rheumatol; 1999 May; 26(5):1134-9. PubMed ID: 10332980
[TBL] [Abstract][Full Text] [Related]
16. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
[TBL] [Abstract][Full Text] [Related]
17. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
Fortin PR; Abrahamowicz M; Ferland D; Lacaille D; Smith CD; Zummer M;
Arthritis Rheum; 2008 Dec; 59(12):1796-804. PubMed ID: 19035431
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
Fautrel B; Borget C; Rozenberg S; Meyer O; Le Loët X; Masson C; Koeger AC; Kahn MF; Bourgeois P
J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
[TBL] [Abstract][Full Text] [Related]
19. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
Smith KG; Jones RB; Burns SM; Jayne DR
Arthritis Rheum; 2006 Sep; 54(9):2970-82. PubMed ID: 16947528
[TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of cyclosporine (Neoral) in rheumatoid arthritis.
Johns KR; Littlejohn GO
J Rheumatol; 1999 Oct; 26(10):2110-3. PubMed ID: 10529125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
